Barbara Hero

14PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersHaematological tumoursPeripheral nervous systemOptometryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

|Dec 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

Nina U Gelineau, Lieke M J van Zogchel, Boris De Carolis

|Dec 12, 2025
Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.

Florian Michallek, Marc Dewey, Barbara Hero

|Aug 03, 2023
Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma.

Sarina K Butzer, Barbara Krug, Maike Reisberg

|Mar 09, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.

Thomas Rossor, E Ann Yeh, Yasmin Khakoo

Pageof 3

Frequent Collaborators

7 joint publications

Thorsten Simon

5 joint publications

Frank Berthold

2 joint publications

Sandra Ackermann

2 joint publications

Gudrun Schleiermacher